Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-24-000047
Filing Date
2024-10-30
Accepted
2024-10-30 06:32:28
Documents
79
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20240930.htm   iXBRL 10-Q 2108234
2 EX-31.1 uthrex31109302024.htm EX-31.1 11943
3 EX-31.2 uthrex31209302024.htm EX-31.2 11949
4 EX-32.1 uthrex32109302024.htm EX-32.1 6653
5 EX-32.2 uthrex32209302024.htm EX-32.2 6780
  Complete submission text file 0001082554-24-000047.txt   9481105

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20240930.xsd EX-101.SCH 53543
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20240930_cal.xml EX-101.CAL 72943
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20240930_def.xml EX-101.DEF 276014
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20240930_lab.xml EX-101.LAB 725239
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20240930_pre.xml EX-101.PRE 496923
82 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20240930_htm.xml XML 1587982
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 241407321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)